STOCK TITAN

AYRO, Inc. 8-K Filings

AYRO NASDAQ

Every 8-K that AYRO, Inc. (AYRO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow AYRO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AYRO filings page.

Rhea-AI Summary

Fabric.AI, Inc. (formerly StableX Technologies) is pivoting from a digital asset treasury strategy to AI infrastructure, launching a MicroLED-based optical interconnect platform with Kopin Corporation and rebranding its name and Nasdaq ticker to “Fabric.AI, Inc.” and “FABC.”

The company entered a Joint Development and License Agreement under which it may pay Kopin up to $15 million for GPU-to-GPU “Project Technology,” with an expected additional $15–25 million under a future production plan and joint ownership of new IP. Kopin will receive Series J preferred shares representing 19.9% of fully diluted common stock (excluding certain equivalents) plus a royalty-free license for defined markets.

Fabric.AI also signed a four-year exclusive Commercial Supply Agreement for products using the new technology and raised $21.5 million gross in a private placement of Series K preferred stock and matching warrants, added new Series J and K preferred structures with 6–7% dividends, extended Series H‑7 and I preferred maturities to 2027, issued additional warrants, refreshed a major consulting agreement, and approved equity awards for its CEO and directors subject to plan share authorization.

Rhea-AI Summary

StableX Technologies, Inc. disclosed new equity awards for leadership. On October 31, 2025, the Board granted stock options covering 311,405 shares to its CEO and non‑employee directors under the company’s Long‑Term Incentive Plan.

CEO Joshua Silverman received options for 220,513 shares, and each non‑employee director — Sebastian Giordano, Zvi Joseph, Greg Schiffman, and Wayne Walker — received options for 22,723 shares. The exercise price equals the greater of $6.25 per share or the fair market value on the grant date. The options have a 10‑year term.

The vesting schedule provides that 75% of each grant vested on the grant date and the remaining 25% vests on December 31, 2025, in each case contingent on continued service. The company’s common stock trades on Nasdaq under the symbol SBLX.

Rhea-AI Summary

StableX Technologies, Inc. reported that stockholders approved all proposals at a special meeting held on October 3, 2025. The key item was a fourth amendment to the company’s 2020 Long-Term Incentive Plan, increasing the total shares of common stock available for equity awards by 135,627 to 400,000 shares. The meeting’s record date was September 5, 2025, when 888,978 common shares and several series of preferred stock were eligible to vote, subject to voting and beneficial ownership limitations described in their certificates of designations. Voting results on each proposal showed strong support, with “For” votes significantly exceeding “Against” and “Abstain” counts, and no broker non-votes.

Rhea-AI Summary

StableX Technologies, Inc. reported another change in its independent auditor, dismissing CBIZ CPAs P.C. on September 18, 2025, and hiring Stephano Slack LLC on September 19, 2025 for the 2025 fiscal year. CBIZ CPAs did not issue any audit reports during its brief engagement, and the company states there were no disagreements on accounting principles, disclosures, or audit scope. The company again notes a previously disclosed material weakness in internal control over financial reporting related to undocumented controls, ineffective control activities, and insufficient segregation of duties in its finance and accounting functions.

Rhea-AI Summary

StableX Technologies, Inc. reported that on September 2, 2025, board member George Devlin voluntarily resigned from the board of directors and from all board committees, effective immediately. The company states that his resignation was not due to any disagreement with its operations, policies, or practices, indicating no disclosed dispute with management or strategy.

In connection with his departure, the board approved a one-time cash payment of $35,437.50 to Mr. Devlin. This amount equals the director cash fees he would have received for service from September 2025 through May 2026 under the company’s board compensation policy.

Rhea-AI Summary

StableX Technologies, Inc., formerly AYRO, Inc., entered into an omnibus amendment to its Series I and Series H-7 warrants and completed a corporate rebranding. The warrant amendment revises how “Fundamental Transactions” and Black Scholes valuation inputs are defined, and removes certain anti-dilution style exercise price adjustments in the Series H-7 warrants. The company also changed its name to StableX Technologies, Inc. effective August 22, 2025, and its Nasdaq ticker switched from “AYRO” to “SBLX” before the market opened on August 25, 2025. A pro forma balance sheet as of June 30, 2025, reflecting the warrant amendment and $6,200,000 in net private placement proceeds, shows pro forma stockholders’ equity of about $4.6 million, which the company believes satisfies Nasdaq’s $2,500,000 minimum equity requirement.

Rhea-AI Summary

AYRO, Inc. entered into a Securities Purchase Agreement to issue a newly designated Series I Convertible Preferred Stock and related warrants to certain accredited investors. The Company agreed to sell an aggregate of 7,000 shares of Series I Preferred Stock with a stated value of $1,000 per share, initially convertible into up to 875,000 shares of common stock at an initial conversion price of $8.00 per share. The transaction also includes warrants to acquire up to an aggregate of 875,000 shares of common stock at an exercise price of $8.00 per share. The Company filed the Certificate of Designations creating the Series I Preferred Stock.

The Company also filed an amendment to its Series H-7 Certificate of Designations that, as disclosed, extends the maturity date to February 4, 2027, revises payment dates and payable amounts for dividends and installment amounts, modifies the definition of "Excluded Securities," and adjusts the schedule of installment dates. Series H-7 holders provided waivers and consents and the Company filed the related Certificate of Amendment. These actions change certain security rights and provide for the issuance of the Series I securities referenced above.

8-K
8-K
Rhea-AI Summary

AYRO (NASDAQ:AYRO) filed an 8-K on June 27 2025 disclosing that it filed a Certificate of Amendment on June 23 2025 to effect a 1-for-16 reverse stock split of its common stock, effective 4:05 p.m. ET on June 25 2025.

The split, approved by shareholders at the May 19 2025 annual meeting, automatically combined every 16 shares into one. Fractional shares are rounded up; the par value remains $0.0001 and authorized shares remain 1.2 billion. Proportional adjustments apply to all outstanding equity awards, warrants and convertible securities.

Split-adjusted trading began on Nasdaq on June 26 2025 under the unchanged ticker AYRO; the new CUSIP is 054748306. No other material modifications were reported.